Skip to main content

Main menu

  • Pipeline
    • Clinical
    • Discovery
    • Compounds
    • Regimens
    • Drug Targets
    • Developers
    • Trial Sites
    • Trials
  • News
  • Meetings
  • Members
    • Our Members
    • Core Group
  • About
  • Join Us

Michael Hoelscher

Submitted by james on Wed, 10/05/2016 - 20:20

  • Read more about Michael Hoelscher

Myriam Haxaire

Submitted by james on Wed, 10/05/2016 - 20:20

  • Read more about Myriam Haxaire

Richard Hafner

Submitted by james on Wed, 10/05/2016 - 20:18

  • Read more about Richard Hafner

Wim Vandevelde

  • Read more about Wim Vandevelde

Albert Makone

  • Read more about Albert Makone

Christian Lienhardt, MD, PhD

  • Read more about Christian Lienhardt, MD, PhD

Tawanda Gumbo

  • Read more about Tawanda Gumbo

Petros C. Karakousis, MD

  • Read more about Petros C. Karakousis, MD

Thomas Dick

  • Read more about Thomas Dick

Mel Spigelman, MD

  • Read more about Mel Spigelman, MD

Pages

  • « first
  • ‹ previous
  • …
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • …
  • next ›
  • last »
Subscribe to Working Group for New TB Drugs RSS
  Would you like to receive updates from the WGND? Join our mailing list:
Interests

About Us

Part of Stop TB Partnership, we are a network of committed individuals devoted to accelerating the development of effective, affordable new therapies for TB.

Visit the Stop TB Partnership
Read about The Global Plan to End TB

Navigate

  • Clinical Pipeline
  • Discovery
  • Developers
  • Trials
  • Trial Sites
  • News
  • Meetings
  • Core Group
  • Members
  • About

Contact

The Working Group for New TB Drugs

80 Pine Street, Fl 20th
New York, NY

Contact Us

Follow Us

©2016 Working Group on New TB Drugs. All Rights Reserved. Terms of Reference Site by Darby Communications